C Ceolin, MV Papa, L Scagnellato, A Doria… - European Geriatric …, 2024 - Springer
Purpose Sarcopenia is a condition defined as loss of muscle mass and strength, associated with poor functional performance and disability. Sarcopenia can be exacerbated or …
Y Xue, J Hu, D Liu, J Li, H Wu, C Tan, L Dai, L Sun, Z Li… - BioDrugs, 2024 - Springer
Introduction Ixekizumab, an interleukin-17A inhibitor, was efficacious and well tolerated for the treatment of active radiographic axial spondyloarthritis (r-axSpA) in international clinical …
S De Mits, TM Willems, P Calders, L Danneels… - The Journal of …, 2024 - jrheum.org
Objective Although exercise therapy is safe, effective, and recommended as a nonpharmacological treatment for axial spondyloarthritis (axSpA), there is a lack of …
R Huang, H Yang, L Chen, S Su, X Wu… - BMC Musculoskeletal …, 2022 - Springer
Background To compare changes in the composition of paraspinal muscles of patients with ankylosing spondylitis (AS) and matched healthy controls using T2 mapping and T2 IDEAL …
JY Lim, SY Lee, HJ Lee, CB Choi, SH Lee… - The Journal of …, 2023 - e-assem.org
Objective: Exercise is an essential element of management for ankylosing spondylitis, of which symptoms and disease activity can be controlled by disease-modifying agents and …
S De Mits, T Willems, P Calders, P Carron - jrheum.org
Objective. Although exercise therapy is safe, effective, and recommended as a nonpharmacological treatment for axial spondyloarthritis (axSpA), there is a lack of …
Pseudomonas aeruginosa is a prevalent pathogen in cystic fibrosis (CF) lungs with elaborate defence mechanisms serving to counter the host immune response. This thesis …